Related references
Note: Only part of the references are listed.GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?
Ana Martinez et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Fragment and knowledge-based design of selective GSK-3 beta inhibitors using virtual screening models
S. Vadivelan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Is malfunction of the ubiquitin proteasome system the primary cause of α-synucleinopathies and other chronic human neurodegenerative disease?
Lynn Bedford et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α-synucleinopathies
G. Muntane et al.
NEUROSCIENCE (2008)
Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3β and the GSK-3β-mediated phosphorylation of myelin basic protein in vitro
Fumitaka Kawakami et al.
JOURNAL OF BIOCHEMISTRY (2008)
Inhibition of GSK-3β mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-κB in rat primary astrocyte
Sun Don Kim et al.
BRAIN RESEARCH (2007)
Regulation of the norepinephrine transporter by α-synuclein-mediated interactions with microtubules
Alexis M. Jeannotte et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Tetyana Duka et al.
FASEB JOURNAL (2006)
The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka et al.
NEUROTOXICITY RESEARCH (2006)
Highly potent and specific GSK-3β inhibitors that block Tau phosphorylation and decrease α-synuclein protein expression in a cellular model of Parkinson's disease
Alan P. Kozikowski et al.
CHEMMEDCHEM (2006)
NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3 beta-induced apoptosis
A Habas et al.
JOURNAL OF NEUROCHEMISTRY (2006)
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
JBJ Kwok et al.
ANNALS OF NEUROLOGY (2005)
Disruption of the interaction of α-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter
C Wersinger et al.
BIOCHEMISTRY (2005)
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M Frasier et al.
EXPERIMENTAL NEUROLOGY (2005)
Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death
G Chen et al.
FASEB JOURNAL (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
RE Drolet et al.
NEUROTOXICOLOGY (2004)
Overexpression of GSK3βS9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3β transgenic mice
BL Li et al.
TRANSGENIC RESEARCH (2004)
Lewy bodies in the amygdala -: Increase of α-synuclein aggregates in neurodegenerative diseases with tau-based inclusions
A Popescu et al.
ARCHIVES OF NEUROLOGY (2004)
GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons
AR Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments
A Gómez-Ramos et al.
BRAIN RESEARCH (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Modulation of dopamine transporter function by α-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress
C Wersinger et al.
FASEB JOURNAL (2003)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
α-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification
N Hishikawa et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex
A Agarwal-Mawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies
T Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Neuroprotective effects of the novel D-3/D-2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
JN Joyce et al.
EXPERIMENTAL NEUROLOGY (2003)
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments
F Hernández et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia:: role of D3 and not D2 receptors
JN Joyce et al.
BRAIN RESEARCH (2002)
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3β
GN Bijur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Lewy body pathology in Alzheimer's disease
PT Kotzbauer et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation
Y Arai et al.
BRAIN RESEARCH (2001)
Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration
RV Bhat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis -: Protection by lithium
GN Bijur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)